Ca
-dependent activator protein for secretion 2 (CAPS2 or CADPS2) potently promotes the release of brain-derived neurotrophic factor (BDNF). A rare splicing form of CAPS2 with deletion of exon3 (dex3) was identified to be overrepresented in some patients with autism. Here, we generated Caps2-dex3 mice and verified a severe impairment in axonal Caps2-dex3 localization, contributing to a reduction in BDNF release from axons. In addition, circuit connectivity, measured by spine and interneuron density, was diminished globally. The collective effect of reduced axonal BDNF release during development was a striking and selective repertoire of deficits in socialand anxiety-related behaviors. Together, these findings represent a unique mouse model of a molecular mechanism linking BDNFmediated coordination of brain development to autism-related behaviors and patient genotype. -dependent activator protein for secretion 2 (CAPS2 or CADPS2) is a member of the CAPS protein family that regulates the trafficking of dense-core vesicles by binding both phosphoinositides and dense-core vesicles (1) (2) (3) (4) (5) . We initially identified mouse Caps2 as a potent factor promoting the release of brain-derived neurotrophic factor (BDNF) during cerebellar development (6, 7) . Our subsequent knockout mouse study showed that Caps2 not only plays a role in neuronal development of the cerebrum and hippocampus as well as the cerebellum, but that it is also associated with social interaction, anxiety, and maternal and circadian behaviors in mice (7, 8) . We also showed that the expression of an exon 3-skipped (or -spliced out) form of CAPS2 (designated CAPS2-dex3) (8) , which is now known to be a rare alternative splicing variant (9, 10) , is increased in a subgroup of patients with autism and is not properly localized in axons (8) . Thus, neurons overexpressing dex3 may fail to coordinate local BDNF release from axons properly (8, 9) , resulting in improper brain development and function. The human CAPS2 gene locus (7q31.32) is intriguingly located within the autism susceptibility locus 1 (AUTS1) (11) on chromosome 7q31-q33, one of several susceptibility loci for autism (12) . Moreover, an association of CAPS2 with autism has been suggested recently, not only by the presence of copy number variations in the CAPS2 gene in autistic patients (13) (14) (15) , but also by decreased transcription of CAPS2 in the brains of people with autism (16) . Thus, clarifying the biological significance of dex3 expression is an important step in elucidating the association of CAPS2 with brain circuit development and behaviors related to autism.
The potential molecular risk factors for autism susceptibility have been increasingly reported (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) but are poorly characterized in animal models. In this report, we generated a mouse model expressing dex3 and analyzed the cellular and autistic-like behavioral phenotypes of dex3 mice. Our results support the involvement of the rare dex3 form of Caps2 in defective axonal BDNF secretion, affecting proper brain circuit development and/ or function, and thereby contributing to an increased susceptibility to autism. Our results suggest that disturbance of the alternative splicing patterns of Caps2 can directly affect normal brain development and function and could contribute to a genetic background of autism susceptibility.
Results

Generation of a Mouse Line Expressing Exon 3-Skipped Caps2 (dex3).
To clarify the in vivo effect of Caps2 exon 3 skipping, we used a Cre/loxP system to generate a mouse line carrying a deletion of exon 3 (which encodes 111 amino acids) of the Caps2 gene, which expresses the exon 3-skipped Caps2 (Caps2-dex3) protein.
A conditional Caps2-dex3 allele was generated by gene targeting in embryonic stem cells (Fig. S1A) . The resultant homozygotes, called Caps2
Δex3/Δex3 mice, produced a Caps2-immunoreactive protein with a slightly lower molecular weight than that of wild types (Fig. S1B) . The Caps2
Δex3/Δex3 mice in standard breeding cages exhibited no differences in life expectancy from control mice, and both male and female Caps2
Δex3/Δex3 mice had normal reproductive ability.
Dex3 Mice Show a Severe Reduction in Caps2 Immunoreactivity in the Projection Areas of Caps2-Expressing Neurons. We first examined the intracellular localization of dex3 protein in vivo using an antiCaps2 antibody. In the cerebellum, wild-type Caps2 protein was mostly localized in the granule cell axons (parallel fibers) extending into the molecular layer ( Fig. 1 A and C) , whereas dex3 protein was not localized in the axons and instead accumulated in the cell somas in the internal granule cell layer ( Fig. 1 B and D) . In the cerebrum of wild-type mice, diffuse signal was widely distributed over the cortical layers, and intense signals were observed in the soma of a subset of interneurons scattered throughout layers II/III and V (Fig. 1E) . Interestingly, in Caps2
Δex3/Δex3 mice, the diffuse signal was almost absent and mostly localized to cell somas in layer V, in addition to some intense signaling seen in interneurons in layers II/III and V (Fig. 1F) . This supported our hypothesis that full-length Caps2 protein [exon3-plus; the dominant form in mouse (27) and human (8) brains] can be transported into axons, whereas dex3 protein (exon3-minus) cannot (8) .
In the wild-type mouse hippocampus, Caps2 protein was expressed in dentate gyrus (DG) granule cells and cornu ammonis region 1 (CA1) pyramidal neurons in addition to a subset of interneurons scattered in the DG and CA1 regions (28) , as shown in Fig. S2A . The latter immunosignal was strong in the cell soma, whereas Caps2 expressed in DG granule cells was localized in axons of the stratum lucidum. In Caps2
hippocampus, diffuse signal of the stratum lucidum was almost diminished, as shown in Fig. S2 B, D , and E.
Decreased Axonal Localization of BDNF in dex3 Neurons. We analyzed the effect of dex3 expression on the axonal localization of BDNF immunoreactivity using primary-cultured hippocampal calbindin-positive granule cells from wild-type and Caps2
Δex3/Δex3 mice. In wild-type neurons (Fig. 2 A-C) , Caps2-immunopositive puncta were localized in the axon, as shown by colocalization with the axonal marker Tau. However, in Caps2
Δex3/Δex3 neurons, Caps2-positive puncta were decreased in the axons (Fig. 2 D-G) . Similarly, as shown in Fig. 2 H-J, BDNF-immunopositive puncta were localized in the axon of wild-type neurons, whereas BDNFpositive puncta were decreased in the axon of Caps2 Δex3/Δex3 neurons ( Fig. 2 K-N) . These data suggest that the axonal localization of BDNF is affected in dex3-expressing neurons.
To exclude the possibility of a defect in cell polarization, we examined the immunoreactivity of MAP2 (a dendritic marker) and Tau (an axonal marker). Both were localized normally in Caps2
Δex3/Δex3 hippocampal cells (Fig. S3 ).
Decreased Axonal Secretion of BDNF in dex3 Neurons. To analyze the axonal release of BDNF in Caps2 Δex3/Δex3 neurons, a BDNFgreen fluorescent protein (GFP) fusion construct was transfected into hippocampal dentate granule cell cultures prepared from either wild-type or Caps2
Δex3/Δex3 mice. KCl-induced (i.e., depolarization-induced) BDNF-GFP release from transfected neurons was evaluated by immunostaining with an anti-GFP antibody before cell permeabilization and by counting immunopositive puncta on axons (Fig. 2O) , as previously reported (29) (30) (31) . The number of cell-surface (i.e., released) BDNF-GFP puncta in KCl-stimulated cells was normalized to that in unstimulated control cells. A graded increase in KCl concentration revealed an activity (depolarization)-dependent release of BDNF-GFP from the axons of wild-type but not Caps2
Δex3/Δex3 cells (Fig. 2P) . These results showed that regulated release of BDNF was impaired in the axons of Caps2 Δex3/Δex3 neurons.
Deficits in Hippocampal and Cortical Interneurons and Dendritic
Spines in dex3 Mice. There is a report showing disrupted architecture in the gamma-aminobutyric acid (GABA)ergic interneuron circuit of the neocortex in autism (32) . It was also shown that differentiation of a subset of neocortical parvalbumin-positive GABAergic neurons is regulated by BDNF (33 and S5 K and L). In the neocortex at either P7 or P21, no difference was observed in the number of calbindin-positive neurons between wild-type and Caps2 Δex3/Δex3 mice (Figs. S4 G and H and S5 M-P). Moreover, there was no significant difference among wild-type (14.02 ± 2.17 cells/mm 2 , mean ± SEM, n = 12), Caps2 +/Δex3 (10.83 ± 2.98 cells/mm 2 , mean ± SEM, n = 10), and Caps2
Δex3/Δex3 (13.45 ± 2.25 cells/mm 2 , mean ± SEM, n = 10) mice in calretinin(+) interneurons of the P21 neocortex. In addition, there was no significant difference in neuronal-specific nuclear protein (NeuN)-positive neurons of the neocortex among the wild-type, Caps2
, and Caps2
Δex3/Δex3 genotypes at P21 (Fig. S6) .
Spine distributions are altered in the developing brain of a large number of genetic conditions that result in mental disorders (34) . Because BDNF affects dendritic protrusion (35), we next analyzed the formation of dendritic protrusions in hippocampal dentate granule cells using Golgi staining (Fig. S7 A and  B) . Dentate granule cells are one of the major neuronal types that secrete BDNF. The total number of dendritic protrusions was decreased in Caps2
Δex3/Δex3 mice compared with wild types (Fig. S7C) . Furthermore, Caps2
Δex3/Δex3 mice displayed a decreased number of spines on the dendrites of dentate granule cells (Fig. S7C) , suggesting that excitatory neurons and synapses are also affected in Caps2
Δex3/Δex3 mice.
Impairments in Behavioral Phenotypes in dex3 Mice. We asked the question whether these cytological and physiological changes in Caps2 Δex3/Δex3 mice affected autism-related behaviors. For the following behavioral studies, we used male mice except for the analysis of maternal behavior.
Motor coordination. First, to assess the cerebellar functions of Caps2
Δex3/Δex3 mice, we tested their coordinated motor performance on a rotarod treadmill. There was no difference in the latency to first fall among wild-type, Caps2
Δex3/Δex3 mice (Fig. 3A) . However, for the average number of falls within a 3-min period at 24 rpm, Caps2
Δex3/Δex3 mice showed low-tomoderate rotarod performance compared with that of their wildtype littermates (Fig. 3B ). In addition, there was no significant difference in performance in a grip traction test among the genotypes (Fig. S8 ). These findings suggest that the drastically altered axodendritic polarity of Caps2 localization in the cerebellum of Caps2
Δex3/Δex3 mice ( Fig. 1 ) impairs their motor coordination ability. Impaired social behavior. An impairment in social interaction is one of the characteristic features of individuals with autism (36, 37) . To investigate the in vivo effect of the Caps2-dex3 variant on social behavior, we tracked the movements of wild-type, Caps2
Δex3/Δex3 mice placed in the center of an open field followed by placing a stranger mouse (C57BL/6J) in a small cage in one corner. When the stranger mouse was introduced, both Caps2 +/Δex3 and Caps2 Δex3/Δex3 mice showed a significant reduction, compared with wild-type mice, in the time spent approaching or interacting with the stranger mouse cage (Fig. 3C) .
We also performed a three-chamber social interaction test (Fig. 3 D and E ). The mouse being tested was placed in the central chamber and could move freely among the three chambers. A stranger mouse was placed in one of the side chambers in a small cage, and an empty cage was placed in the opposite chamber. Wild-type mice tended to contact the stranger mouse, and the time spent in the quadrant containing the stranger mouse was significantly higher than the time spent in the corresponding quadrant in the opposite chamber containing the empty cage. Caps2 Δex3/Δex3 mice also spent a little more time with the stranger mouse than with the empty cage, but the difference was not significant (Fig. 3D ). It is possible that this is because of an impairment in spatial recognition memory. Therefore, we tested Caps2
Δex3/Δex3 mice in a Y-maze test. This indicated no impairment in spatial recognition memory in Caps2
Δex3/Δex3 mice (Fig. S9A ). Next, we compared social interactions with either novel (unfamiliar) or familiar mice. Wild-type mice tended to contact a stranger mouse rather than a familiar mouse, whereas there was no significant difference for Caps2
Δex3/Δex3 mice (Fig. 3E ). This result might be because of an impairment in olfaction. Therefore, we measured the olfactory ability of Caps2 mice by measuring the time to find hidden cookies (Materials and Methods). This indicated no impairment in basic olfactory function in Caps2
Δex3/Δex3 mice (Fig. S9B ). Our data suggest that wild-type mice are more interested in a novel mouse than a familiar mouse, and that Caps2
Δex3/Δex3 mice have decreased sociability compared with the wild types; this may be analogous to the impairment in appropriate social interactions often seen in autistic patients (38) . Exploratory and anxiety-related behavior. The Caps2
Δex3/Δex3 mice showed decreased exploratory behavior and/or increased anxiety in a novel environment. Caps2
Δex3/Δex3 mice placed in an open field showed normal locomotor activity (Fig. S10A) and speed (Fig. S10B ) compared with their wild-type littermates. However, when placed in an open field containing a novel object in the central area (the black-and-white vertical object shown in the Inset of Fig. 4A ), Caps2
Δex3/Δex3 mice became less active (Fig. 4A ) without changing their speed of movement (Fig. 4B ) and tended to contact the novel object less frequently than wild-type mice did (Fig. 4C) . Representative traces from wild-type, Caps2
Δex3/Δex3 mice are shown in Fig. 4D . In the elevated plus maze test, there was no difference in horizontal distance moved, suggesting that locomotor activity in this test was not affected by exon 3 skipping (Fig. 4E) . However, the Caps2
Δex3/Δex3 mice spent less time in the open arms than did the wild types (Fig. 4F) . In addition, the number of open-arm entries was decreased (Fig. 4G) . Representative traces from wild-type, Caps2
Δex3/Δex3 mice are shown in Fig.  4H . However, Caps2
Δex3/Δex3 mice showed no significant anxietylike behavior in the light/dark transition test (Fig. S11 A-C), indicating that their tendency to display increased anxiety-like behavior might depend on the particular behavioral test used; for example, they may be more sensitive to novelty or unfamiliarity than to a light/dark preference.
In the home cage, locomotor activity was similar between Caps2
Δex3/Δex3 mice and their wild-type littermates when measured during a 3-d period (12-h light/dark cycle) after habituation to a fresh home cage for 24 h (Fig. S12) . However, in the dark period of the 24-h cycle, even on the third day, both Caps2
Δex3/Δex3 and Caps2 +/Δex3 mice exhibited reduced locomotion activity compared with wild-type mice (Fig. 4I) , suggesting that Caps2
Δex3/Δex3 and Caps2 +/Δex3 mice do not adapt well to a new environment. Decreased dam-pup interaction and communication. To evaluate whether the maternal behavior of Caps2
Δex3/Δex3 mice was affected, we monitored the nurturing of newborns by their mothers, to assess maternal care as an important social interaction between dams and pups. To exclude the effect of pup genotype, Caps2 +/Δex3 pups were used for this experiment. In many cages, the newborns of a Caps2
Δex3/Δex3 dam and a wild-type sire rarely survived beyond P1 (Fig. 4J) . In contrast, the newborns of a Caps2
Δex3/Δex3 sire and a wild-type dam normally survived beyond P1 (Fig. 4J) . These results indicated that Caps2
Δex3/Δex3 mothers display defective maternal behavior.
To investigate communication ability from pups to their dam, we studied the ultrasound vocalization (USV) of neonates using Caps2 +/Δex3 mice. To exclude the effect of sire genotype, wild-type or Caps2
Δex3/Δex3 males were mated with wild-type females. The resultant wild-type or Caps2 +/Δex3 pups were used to monitor USV. We found that the duration of USVs decreased from P5 to P10 in wild-type pups, but that Caps2 +/Δex3 pups emitted very few USVs throughout this period (Fig. S13 ). This suggests that the skipping of exon 3 affects the dam-pup interaction by USV calls. Impaired circadian rhythm. Autism is frequently accompanied by an abnormal sleep-wake rhythm (39, 40) . Regarding the circadian rhythm of locomotor activity under a 12-h light/dark cycle, we detected no differences in the sleep-wake rhythm among wildtype, Caps2 +/Δex3 , and Caps2 Δex3/Δex3 mice. Under constant dark conditions, the sleep-wake rhythm of the Caps2
Δex3/Δex3 mice showed a shorter period than that of wild-type mice. However, there was no statistically significant difference among the three genotypes (Fig. S14A) , because some Caps2
Δex3/Δex3 mice (4/14) showed impaired circadian rhythmicity (Fig. S14C ) compared with wild types and this resulted in a large variance (Fig. S14B) . stranger mouse (S2) was placed in a cage in one side chamber, and a familiar mouse (S1), which was used in the test shown in D, was placed in the other side chamber. Error bars indicate SEM. *P < 0.05; **P < 0.01, by post hoc t test.
Discussion
In this report, we developed a mouse line expressing exon 3-deleted Caps2 (dex3), the same as a rare alternatively spliced variant of human CAPS2 that was identified in some individuals with autism (8). Caps2-dex3 mice displayed deficits in axonal localization in cerebral, hippocampal, and cerebellar neurons, resulting in decreased local secretion of BDNF from axons. This local loss of BDNF was associated with a development-dependent decrease in the number of hippocampal and cortical parvalbumin-and calbindin-positive interneurons, as well as a decreased number of dendritic spines in the dentate granule cells. Moreover, we showed that Caps2-dex3 mice displayed increased anxiety in an unfamiliar environment and impaired social behavior and circadian rhythmicity. These lines of in vivo evidence support the idea that disturbance in the proper levels of local BDNF release, which we assume to be caused here by aberrant subcellular targeting of Caps2, contributes to the abnormal circuit connectivity observed in autism (41) . Previous studies reported that decrease of the BDNF-tyrosine kinase B (TrkB) signal cascade caused reduction of parvalbumin (+) neurons (33, 42) . Our results showed a decreased number of parvalbumin(+) neurons in P21 homozygote neocortex, although the number of other interneurons and NeuN(+) neurons was unchanged, suggesting that parvalbumin(+) interneurons, a minor cell type, were specifically affected in the neocortex of homozygotes. However, it cannot be ruled out that the apparent reduction in the number of parvalbumin(+) neurons was due to a decrease in the expression level of parvalbumin, without loss of neurons.
One of the symptoms of autism is augmented anxiety and/or reduced environmental exploration in a novel environment. Novel stimuli, such as unfamiliar environments or objects, are theorized to create conflict in rodents by concurrently evoking both approach and avoidance behaviors (43) . Approach behavior or "exploration" reflects an animal's tendency to explore novel stimuli or environments, whereas avoidance behavior or "anxietyrelated behavior" is thought to reflect an animal's fear of novelty. In this report, Caps2
Δex3/Δex3 mice showed decreased locomotor activity compared with wild-type mice when placed in an open field containing a novel object. Moreover, Caps2
Δex3/Δex3 mice tended not to contact a novel object. Overall, Caps2
Δex3/Δex3 mice tended to show augmented anxiety or reduced environmental exploration in a novel environment. Caps2 Δex3/Δex3 mice showed impairments in both social interaction and social novelty preference. Caps2 +/Δex3 mice also exhibited a significant reduction in interaction activity, suggesting that a social behavioral deficit might be attributable to the approximately equal balance of dex3-minus vs. dex3-plus isoform expression (Fig. S1B ) that was found in some autistic patients (8) . The link between social behavior in rodents and humans is difficult to establish. Our model may provide a powerful tool to explore its mechanisms.
Recently, it was suggested that splicing dysregulation is an underlying mechanism of neuronal dysfunction in autism (16) . However, it remains unclear how the increased removal of exon 3 of CAPS2 is specifically caused in certain autistic patients. We did not find any nucleotide sequence differences in the three common splicing cis-elements (the 5′ donor and 3′ acceptor sites and the branch point) of the CAPS2 gene in autistic patients displaying exon 3 skipping (8). We also examined the sequence of introns 2 and 3 in the autistic subjects, and we found some variants specifically identified in patients displaying increased exon 3 skipping. We are currently investigating the association of these variants with exon 3 skipping. We must also consider the possibility that there is a polymorphism(s) in an unknown gene(s), which alters the splicing of CAPS2 mRNA (10) . This scenario would predict the abnormal splicing of multiple genes besides CAPS2. However, the Caps2 Δex3/Δex3 
. (I) Caps2
Δex3/Δex3 mice displayed impaired habituation to a fresh cage. After habituation to a fresh cage for 24 h, the locomotor activity of wild-type (n = 11), Caps2 +/Δex3 (n = 13), and Caps2 Graph shows the survival of pups born to primiparous wild-type (open diamonds; n = 12) and Caps2 Δex3/Δex3 (black diamonds; n = 13) females.
Error bars indicate SEM. P < 0.01, repeated measures ANOVA. **P < 0.01, by post hoc u test.
mice, in which only Caps2 was mutated, showed autistic-like phenotypes, arguing against the involvement of other abnormally spliced genes. This causality is reminiscent of that between mutation of Mecp2 (the cause) and altered expression of BDNF (the effect) in Rett syndrome. Bdnf is one of the affected genes in Mecp2-knockout mice; however, BDNF is strongly associated with the symptoms of Rett syndrome (44, 45) . Clearly, the genetic involvement for autism is complex, but our approach of model validity-reverse engineering a mouse model for autistic patients with overexpression of a dex3 isoform of CAPS2, which shows relevant phenotypes-is certainly promising.
Materials and Methods
Animals. All experimental protocols were approved by the RIKEN Institutional Animal Care and Use Committee. Mice were housed on a 12-h light/dark cycle, with the dark cycle from 20:00-08:00.
Generation of Caps2 Exon 3-Skipped Targeting
Vector. An 11-kb genomic fragment containing exon 3 of the mouse Caps2 gene was obtained from the genomic DNA of C57BL/6 mice and was used to construct the targeting vectors (Fig. S1A) . One loxP sequence was inserted at the BtrI site, and the phosphoglycerate kinase-neomycin resistance (neo) cassette, flanked by another loxP sequence and a pair of frt sequences, was inserted into the AatII site upstream of exon 3, to generate a loxP-frt-neo-frt-exon3-loxP cassette. For negative selection, the diphtheria toxin A-fragment gene cassette was added to the 3′ end of the targeting vector. Generation of Caps2 exon 3-skipped mice, primaryculture, immunohistochemistry, immunocytochemistry, and behavioral tests are described in detail in SI Materials and Methods. -dependent activator protein for secretion 2 (Caps2) (1:10,000 dilution) (1) and mouse monoclonal antiactin (1:500 dilution; A4700; SigmaAldrich). The following primary antibodies were used for immunohistochemistry and immunocytochemistry: guinea pig polyclonal anti-Ca 2+ -Caps2 (1:5,000 dilution) (1), rabbit polyclonal anti-brain-derived neurotrophic factor (BDNF) (1:100 dilution) (2), rabbit polyclonal anti-green fluorescent protein (GFP) (1:400 dilution; A11122; Life Technologies), anti-MAP2(a+b) (1:1,000 dilution; M1406; Sigma-Aldrich), mouse monoclonal antiparvalbumin (1:4,000 dilution; P3088; Sigma-Aldrich), mouse monoclonal anti-Tau (1:300 dilution; 610672; BD Biosciences), rabbit polyclonal antisynaptophysin (1:100 dilution; RB-1461-P0; Thermo Scientific), and rabbit polyclonal anticalbindin (1:1,000 dilution; AB1778; Millipore). A polyclonal antibody was raised against recombinant human BDNF (whole BDNF) in male New Zealand white rabbits (Japan SLC) (2). Purified anti-BDNF antibody was tested for specific reactivity with the antigen (recombinant human BDNF) but not with mouse nerve growth factor (NGF) or recombinant human neurotrophin-3 (NT-3) (2). It was also confirmed that the purified anti-BDNF antibody could immunoreact with specific areas of the hippocampus in wild-type mice but not in BDNF-knockout mice (3).
Generation of Caps2 Exon 3-Skipped Mice. After transfecting MS12 embryonic stem (ES) cells (a C57BL/6 mouse ES cell line) (4) by electroporation, targeted clones were screened for G418 resistance with the targeting vector and analyzed by Southern blotting. Chimeric mice were generated by injection of targeted MS12 ES cells into mouse BALB/c blastocysts; the chimeras were mated with wild-type C57BL/6J mice to obtain heterozygous mutant mice. All of the engineered animals studied were backcrossed with C57BL/6J mice for more than five generations.
Immunohistochemistry. C57BL/6J male mice were killed by anesthesia with diethyl ether. Mice were transcardially perfused, initially with PBS and then with Zamboni's fixative [2% (wt/vol) paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, containing 0.2% picric acid]. Tissues were dissected, postfixed in Zamboni's fixative at 4°C for 5 h, and cryoprotected by immersion in 15% (wt/vol) sucrose in PBS overnight at 4°C. After embedding in Tissue-Tek OCT compound (Sakura Finetechnical), tissues were frozen in dry ice powder, and sectioned at a thickness of 14 μm using a cryostat (CM1850; Leica Microsystems) at −18°C. The sections were air dried for 1 h and rinsed three times in PBS. After blocking with 5% (wt/vol) BSA and 0.3% Triton X-100 in PBS at room temperature (RT) for 1 h, the sections were reacted at 4°C overnight with primary antibody in an immunoreaction buffer [2× PBS containing 0.3% Triton X-100 and 1% (wt/vol) BSA], rinsed in PBS, and then reacted at RT for 1 h with secondary antibody in the same immunoreaction buffer, and rinsed again in PBS. Immunoreacted sections were mounted with Vectashield mounting medium (Vector Laboratories) and observed using a microscope (BX51; Olympus) equipped with a charge-coupled device (CCD) camera (VB-7000; Keyence). Digital images were processed using Adobe Photoshop 6.0 software (Adobe Systems).
Immunocytochemistry. Cells were fixed with Zamboni's fixative at RT for 15 min. After washing three times with PBS, cells were permeabilized in PBS containing 0.02% Triton X-100 at RT for 5 min. After blocking with Image-iT FX signal enhancer (Invitrogen) at RT for 60 min, cells were incubated with primary antibodies at 4°C overnight, rinsed in PBS, then incubated with Alexa-conjugated secondary antibodies (1:1,000 dilution; Invitrogen) at RT for 1 h, and again rinsed in PBS. Immunoreacted cells were mounted with Vectashield mounting medium (Vector Laboratories). Images were acquired with a microscope (BX51; Olympus) equipped with a CCD camera (VB-7000; Keyence). Digital images were processed using Adobe Photoshop 6.0 software (Adobe Systems).
Primary Cultures of Hippocampal Granule Cells. Primary-cultured hippocampal granule cells from mice were prepared using previously described methods (5), with slight modifications. Briefly, three-day-old C57BL/6J mice (Nippon SLC) were deeply anesthetized by ether, and the hippocampal formation was immediately dissected and placed in ice-cold Gey's balanced salt solution bubbled with a gas mixture of 95% O 2 and 5% CO 2 . After removal of the subicular complex along the sulcus hippocampi, the remaining part was divided into the dentate gyrus and Ammon's horn. Both tissues were cut into pieces and treated with 0.25% trypsin (Difco Laboratories) and 0.01% DNase I (Sigma-Aldrich) at 37°C for 30 min. The incubation was terminated by the addition of heat-inactivated horse serum. The tissue fragments were centrifuged at 250 × g for 5 min, the supernatant was removed, and the pellet was resuspended in a mixture of 50% Neurobasal/ B-27 and 50% astrocyte-conditioned medium. The cells were plated at a density of 5.0 × 10 4 cells/cm 2 onto poly-L-lysine-coated cell culture plates. To prevent proliferation of glial cells, the culture medium was changed to conditioned medium-free neurobasal/B-27 medium supplemented with 2 μM cytosine-D-arabino-furanoside (Sigma-Aldrich) 24 h after plating. Half of the medium was exchanged every 3 d.
On days in vitro (DIV) 6, neurons were transfected with BDNF-GFP using Lipofectamine 2000 (Invitrogen). Twenty-four hours after transfection, cultured neurons were stimulated with medium containing various concentrations of KCl for 10 min, fixed with 4% (wt/vol) paraformaldehyde (PFA)/PBS, and then washed with PBS. After blocking with 5% (vol/vol) normal donkey serum/PBS (Vector Laboratories), cells were incubated with anti-GFP antibody at RT for 2 h, rinsed in PBS, permeabilized, incubated with anti-MAP2(a+b) antibody at RT for 2 h, rinsed in PBS, incubated with Alexa Fluor-conjugated secondary antibody at 4°C overnight, and then rinsed in PBS. Immunoreacted cells were mounted with Vectashield mounting medium (Vector Laboratories). Images were acquired with a microscope (BX51; Olympus) equipped with a CCD camera (VB-7000; Keyence). Digital images were processed using Adobe Photoshop 6.0 software (Adobe Systems).
Behavioral Tests. Two-month-old male mice were used unless otherwise described. All mice used were the littermate progeny of intercrossed heterozygotes. The experimenter was blind to the genotype. Rotarod testing. Rotarod testing was carried out as described previously (6) using a Rota-Rod Treadmill for Mice 7600 (Ugo Basile). All mice used in the experiments below were littermates from mated heterozygotes. Briefly, a male mouse was required to run backward to maintain its position on top of a rod revolving at 24 rpm. Each time it fell, the mouse was put back on the rod until it had run for a total of 3 min on the rod. The time was not counted while the mouse was off the rod. The latency to first fall and the total number of falls within 3 min were recorded. Grip traction test. Muscle strength was tested by a mouse's ability to hang on by its forepaws to a horizontal wire placed above the table. The time during which the mouse remained hanging was recorded (7) . Open-field test and novel object recognition test. The test was performed as previously described (8, 9) with minor modifications. Locomotor activity was measured in an open field (60 × 60 cm) at 50 lx (at the surface level of the area). Each mouse was placed in the center of the open field, and its horizontal movements were monitored for 15 min with a charge-coupled device camera. The images were processed with National Institutes of Health (NIH) Image Open Field (O.F.) software (O'Hara & Co.). Social interaction test. The social interaction test was performed as previously described (8) with minor modifications. A vacant small cage was placed in the home cage with the subject for 24 h. Social interaction was measured in the open field apparatus described above. A small cage containing a stranger C57BL/6J mouse was placed in one corner. Each mouse was placed into the open field for 15 min. Y-maze test. Spontaneous alternation to explore new environments was assessed to test spatial recognition memory as described previously (10) . The acrylic symmetrical Y maze consists of three arms (40 × 3 cm) each separated by 120°, with 13-cm-high transparent walls (O'Hara & Co.). Each mouse (11-13 wk of age) was placed in the center of the Y maze and allowed to explore freely for 5 min. The sequence and total number of arms entered were recorded. The percentage of alternation is the number of triads containing entries into all three arms divided by the maximum possible number of alternations (total number of arm entries − 2) × 100. Olfactory test. The hidden-cookie test was performed as previously described (11) . Male mice (n = 9 of each genotype) were food deprived overnight. A piece of butter cookie (Morinaga, <0.7 g per piece) was buried beneath about 3 cm of clean bedding in a random location. The mouse was placed in the cage, again in a random location, during the light phase. The latency time to locate the cookie was recorded. We defined finding the cookie as when the mouse held it in both paws. Elevated plus maze. The elevated plus maze was set at a height of 65 cm and consisted of four gray plexiglass arms, each 8-cmwide × 25-cm-long with 15-cm-high walls. Two arms were open, and two were enclosed. Individual mice were placed in the center of the maze, and the total distance and time spent in each arm were measured, and analyzed with NIH Image Elevated Plus (E.P.) software (O'Hara & Co.). Light/dark transition test. The light/dark transition test was performed as previously described (12) . The apparatus consisted of a cage (40 × 20 × 20 cm) bisected by a black partition containing a small opening (O'Hara & Co.). One chamber was open and brightly illuminated, whereas the other chamber was closed and dark. Mice were placed into the dark side and allowed to move freely between the two chambers for 10 min. The time spent in the light side was recorded, and analyzed with NIH Image Light/ Dark (L.D.) software (O'Hara & Co.). Home-cage activity. Home-cage activity was measured as previously described (13) . Spontaneous locomotor activity in the home cage (18 cm wide × 14 cm high × 32 cm deep) was determined by counting photobeam interruptions using SCANET (6 channel SV-20 system; Melquest) for 6 d, after 24 h habituation to a fresh cage. The distance between the sensors was 0.5 cm. Mice were housed individually under the 12-h light/dark cycle described above. Food and water were available ad libitum. The experiment was begun at 08:00, and lasted 3 d. Neonate survival test. The mice used were 2-mo-old primiparous females. Wild-type females were mated with Caps2
Δex3/Δex3 males, and vice versa. Pregnant wild-type or Caps2
Δex3/Δex3 females were housed separately and were not touched for at least 5 d before giving birth. Ultrasound vocalization test. Animals were assessed for ultrasound vocalization (USV) between P5 and P10. Wild-type females were mated with wild-type or Caps2
Δex3/Δex3 males. The pups were separated from their dam immediately before recording and were positioned in a sound-attenuating chamber below a condenser ultrasound microphone (40011; Avisoft Bioacoustics) to detect USVs at 50-100 kHz. The duration of calls was recorded and quantified with an Avisoft recorder (Avisoft Bioacoustics) during a 10-min test. Recording of circadian rhythm. Circadian rhythm was recorded as previously described (14) . Wheel running was measured with a wheel meter (WW-3302; O'Hara & Co.), which comprises a set of 20 rooms (14.3 cm wide × 14.8 cm high × 29.3 cm deep) containing a wheel cage (50 cm diameter × 5 cm wide). The mice were housed one per room, were able to move freely, and were given free access to food and water. Every 1/3 revolution of the wheel cage was recorded as one count. The circadian period was calculated using a χ 2 periodogram. , and 16, respectively) (P < 0.01, one-factor ANOVA). (E) P7 hippocampus (n = 9, 18, and 12, respectively) (P < 0.01, one-factor ANOVA). (F) P21 hippocampus (n = 6, 6, and 8, respectively). (G) P7 neocortex (layers II-V) (n = 9, 8, and 12, respectively). (H) P21 neocortex (layers IV-V) (n = 8, 9, and 11, respectively). Error bars indicate SEM. *P < 0.05; **P < 0.01, by post hoc t test. Error bars indicate SEM. *P < 0.05, by Student t test. Fig. S8 . Grip traction test. Time during which the mice remained hanging from a horizontal wire is presented for wild-type (white; n = 9), Caps2 +/Δex3 (gray; n = 9), and Caps2
Δex3/Δex3 (black; n = 9) mice. Error bars indicate SEM. Δex3/Δex3 (black; n = 9) mice. (B) Latency to locate a piece of cookie was recorded. We defined finding the cookie as when the mouse held it in both paws. No significant differences were observed among wild-type, Caps2 +/Δex3 , and Caps2 Δex3/Δex3 mice in these tests. Δex3/Δex3 males. The developmental change in USVs is shown for wild-type (open circles; n = 7 litters) and Caps2 +/Δex3 (gray circles; n = 8 litters) pups. Error bars indicate SEM. P < 0.01, repeated measures ANOVA. *P < 0.05; **P < 0.01, by post hoc u test.
